The shenanigans cited by a California judge are typical of cases where U.S. "multinationals" are shaken down by trial lawyers supported by populist, politicized foreign courts.

In order to sustain an intelligent system of health justice, we must insist on a judiciary that upholds the law and refrains from legislating from the bench.

The $2 billion loss at JPMorgan Chase (JPM) has reopened debate on the Volcker rule. The proponents of the rule have seized on the story as proof that the Volcker rule is necessary and should be quickly put into effect by regulation. In reality, however, if the facts are as thus far reported, what happened at JPMorgan is proof that the Volcker rule is unworkable and should be repealed. 

So the Democrats' drug-safety concerns were about enriching the plaintiffs' bar?

So the Democrats' drug-safety concerns were about enriching the plaintiffs' bar?

The Chen Guangcheng saga gets stranger and stranger, but also is becoming a major diplomatic embarrassment for the Obama administration.

What matters for China is not whether Westerners believe the system is cracking. The question is: How do the Chinese view their own system?

With Friday marking the two year anniversary of ObamaCare and oral arguments before the Supreme Court set to begin next week, American Enterprise Institute experts Thomas Miller and Karlyn Bowman are available for interviews.